Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype-Reference-Cited by-同舟云学术

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

Published:2017-04-11 Issue:24 Volume:8 Page:39367-39381
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kwon Yujin¹,Park Minhee¹,Jang Mi¹,Yun Seongju¹,Kim Won Kyu¹,Kim Sora²,Paik Soonmyung²,Lee Hyun Jung³,Hong Sungpil³,Kim Tae Il³,Min Byungsoh⁴,Kim Hoguen¹

Affiliation:

1. Department of Pathology and BK21 for Medical Science, Yonsei University College of Medicine, Seoul, Korea

2. Severance Biomedical Science Institute and BK21 for Medical Science, Yonsei University College of Medicine, Seoul, Korea

3. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea

4. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NXPH4 mediated by m5C contributes to the malignant characteristics of colorectal cancer via inhibiting HIF1A degradation;Cellular & Molecular Biology Letters;2024-08-20

2. Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer;International Journal of Cancer;2024-08-08

3. AEG-1 as a Novel Therapeutic Target in Colon Cancer: A Study from Silencing AEG-1 in BALB/c Mice to Large Data Analysis;Current Gene Therapy;2024-08

4. Expression characteristics of tumors as prognostic and predictive markers for resectable and locally advanced colorectal cancer;Russian Journal of Biotherapy;2024-06-26

5. DeepTraSynergy: drug combinations using multimodal deep learning with transformers;Bioinformatics;2023-07-19